Bifogade filer
Prenumeration
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Bioteknik |
THIS PRESS RELEASE MAY NOT BE PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SOUTH AFRICA, SWITZERLAND, SINGAPORE, THE UNITED KINGDOM, UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH ACTION IS SUBJECT TO LEGAL RESTRICTIONS IN WHOLE OR IN PART. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO ACQUIRE SECURITIES IN MODUS THERAPEUTICS HOLDING AB. SEE ALSO THE "IMPORTANT INFORMATION" SECTION BELOW.
The Board of Directors of Modus Therapeutics Holding AB ("Modus" or the "Company") has, in connection with the rights issue of units announced on June 26, 2025 (the “Rights Issue"), prepared a Swedish language EU Growth Prospectus (the “Prospectus") which today has been approved and registered by the Swedish Financial Supervisory Authority.
Publication of Prospectus
The Prospectus has been prepared in connection with the Rights Issue and has today, on August 11, 2025, been approved and registered with the Swedish Financial Supervisory Authority. The Prospectus, containing complete terms and instructions, as well as subscription forms, is available on the Company's website (www.modustx.com) and on the website of Bergs Securities (www.bergssecurities.se). The Prospectus will also be available on the website of the Swedish Financial Supervisory Authority (www.fi.se).
Summary of the Rights Issue
- One (1) existing share in the Company on the record date, which was on August 8, 2025, entitles to one (1) unit right. Four (4) unit rights entitle the holder to subscribe for one (1) unit consisting of nine (9) shares, three (3) warrants of series TO 2026 and four (4) warrants of series TO 2030
- The subscription price is SEK 3.15 per unit, corresponding to SEK 0.35 per new share. The warrants are issued free of charge
- Trading in unit rights will take place during the period from August 12 – August 21, 2025
- The subscription period runs from August 12 – August 26, 2025
The Rights Issue is fully covered by subscription commitments and guarantee undertakings. Neither subscription commitments nor guarantee undertakings are secured by bank guarantees, blocked funds, pledged assets or similar. For further information about the Rights Issue, please refer to the published Prospectus.
Advisors
Bergs Securities is sole manager and bookrunner and Advokatfirman Vinge is legal advisor to Modus in connection with the Rights Issue.